COVID-19 biospecimens are available through the Tissue Procurement Core (TPC). Please contact Brian Goetz (email@example.com) for a cost estimate for biospecimen distribution. An IRB approval letter may need to be submitted to the TPC. The TPC will create a new project within Open Specimen, and samples will be distributed. To request clinical data from samples collected under WU350, after IRB approval is received, investigators may contact Drs. Jane O’Halloran and Chuck Goss for access to this data. To request clinical data from WU353 (donor plasma), after IRB approval is received, investigators may contact Drs. Jane O’Halloran, Rachel Presti, or Chuck Goss for access to this data.
Funding Acknowledgement for COVID-19 Biorepository
Any publication that used samples from the Washington University COVID-19 biorepository must cite the following support:
“This study utilized samples obtained from the Washington University School of Medicine’s COVID-19 biorepository, which is supported by: the Barnes-Jewish Hospital Foundation; the Siteman Cancer Center grant P30 CA091842 from the National Cancer Institute of the National Institutes of Health; and the Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the view of the NIH.”